The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Angiotensin analogues palmitoylated in positions 1 and 4.EBI
Universit£
Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.EBI
China Pharmaceutical University
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.EBI
Dupont Pharmaceuticals
Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids.EBI
Takeda Chemical Industries
 
(6-oxo-3-pyridazinyl)-benzimidazoles as potent angiotensin II receptor antagonistsEBI
TBA
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.EBI
The M. S. University of Baroda
 
Uracil-based angiotensin II receptor antagonistsEBI
TBA
 
A new class of angiotensin II receptor antagonists with a novel acidic bioisostereEBI
TBA
 
2,3,6-Substituted quinazolinones as angiotensin II receptor antagonistsEBI
TBA
 
6-Substituted Quinazolinone Angiotensin II Receptor AntagonistsEBI
TBA
 
Synthesis and biological evaluation of the potent isoxazolidinyl angiotensin II receptor antagonist CL332,877 and its enantiomers.EBI
TBA
 
6-isoxazolinyl and isoxazolidinyl substituted quinazolinones as angiotensin II receptor antagonistsEBI
TBA
 
A new class of diacidic nonpeptide angiotensin II receptor antagonistsEBI
TBA
 
Discovery and development of aryl-fused imidazole-based angiotensin II antagonistsEBI
TBA
 
Substituted 4H-pyrido[1,2-a]pyrimidin-4-one angiotensin II receptor antagonists.EBI
TBA
 
Angiotensin II receptor antagonists: imidazoles and pyrroles bearing hydroxymethyl and carboxy substituentsEBI
TBA
 
New non-peptide angiotensin II receptor antagonists. 2: structure - activity relationship of a series of annelated 2(1H)-pyridinonesEBI
TBA
 
Substituted pyrrolidin-2-one biphenyltetrazoles as angiotensin II antagonistsEBI
TBA
 
Substituted piperidin-2-one biphenyltetrazoles as angiotensin II antagonistsEBI
TBA
Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring.EBI
Chinese Academy of Sciences
Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.EBI
China Pharmaceutical University
Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds.EBI
Sankyo
N-3-substituted pyrimidinones as potent, orally active, AT1 selective angiotensin II receptor antagonists.EBI
Istituto Lusofarmaco